SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Religare Enterprises advances on inking agreement to sell 80% stake in RHI

10 Apr 2017 Evaluate

Religare Enterprises is currently trading at Rs. 227.05, up by 8.70 points or 3.98% from its previous closing of Rs. 218.35 on the BSE.

The scrip opened at Rs. 228.95 and has touched a high and low of Rs. 230.00 and Rs. 228.30 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 294.90 on 08-Apr-2016 and a 52 week low of Rs. 209.00 on 10-Mar-2017.

Last one week high and low of the scrip stood at Rs. 234.00 and Rs. 216.00 respectively. The current market cap of the company is Rs. 4,070.00 crore.

The promoters holding in the company stood at 50.93%, while Institutions and Non-Institutions held 20.57% and 28.51% respectively.

Religare Enterprises (REL) has entered into a definitive agreement with a consortium of investors led by True North (formerly India Value Fund) to buy out its entire stake in Religare Health Insurance Company (RHI). The consortium includes domestic investors such as Gaurav Dalmia and Faering Capital. JP Morgan acted as the exclusive financial advisor to Religare Enterprises on this transaction.

This transaction values RHI at Rs 1,300 crore and REL currently has 80% shareholding on a fully diluted basis in RHI. The transaction marks the single largest investment in a standalone health insurance company in India. The transaction is subject to necessary regulatory approvals.

Religare Enterprises is one of India’s leading diversified financial services groups. It offers an integrated suite of financial services including asset management, life and health insurance, lending, broking, investment banking, and wealth management.




Religare Enterprises Share Price

223.60 3.20 (1.45%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×